SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001370053-24-000019
Filing Date
2024-04-24
Accepted
2024-04-24 16:05:50
Documents
8
Period of Report
2024-06-12

Document Format Files

Seq Description Document Type Size
1 DEF 14A proxystatementfy2023_def14a.htm DEF 14A 806019
2 anaptysbioproxycard_1.jpg GRAPHIC 1330105
3 anaptysbioproxycard_2.jpg GRAPHIC 206627
4 compensationvsnetincomev2.jpg GRAPHIC 78803
5 compensationvstsrv2.jpg GRAPHIC 77560
6 dfsignature.jpg GRAPHIC 4102
7 johnorwinsignature.jpg GRAPHIC 5703
8 newlogo.jpg GRAPHIC 50475
  Complete submission text file 0001370053-24-000019.txt   3220602
Mailing Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE, SUITE 210 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO, INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37985 | Film No.: 24870563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)